Global webcast on cognitive challenges in progressive MS

If you missed the latest live-stream from the International Progressive MS Alliance, don’t worry you can catch up now!

Cognitive impairment is common in MS, and people with MS frequently report difficulties, such as following along in complex conversations, recalling information and forgetfulness. These cognitive challenges can impact the successful completion of everyday tasks. Fortunately, there are proven strategies that can help manage these challenges and research is providing insights into new solutions for people with progressive MS.

Learn about the latest advances in treatment and research in cognition and MS during this global webcast. From simple ways to manage or reduce cognitive challenges to research seeking the cause and developing new treatments, this webcast provides information to help improve your quality of life and keep you informed.

Catch-up now!

Watch the webcast below and keep scrolling to read more about the host and expert panel. Click the settings toggle in the bottom right corner to watch the video with English, Spanish, Italian, Arabic, French or Czech subtitles.

Catch-up on the previous Alliance webcasts here.

Webcast Panel

Nancy D. Chiaravalloti, PhD is Director of Neuropsychology, Neuroscience and Traumatic Brain Injury Research at Kessler Foundation and Research Professor of Physical Medicine and Rehabilitation at Rutgers University, New Jersey Medical School. She has received over $23 million in grant funding and published over 200 peer-reviewed manuscripts, including a book on changes in everyday life following brain injury and illness. She has also made hundreds of national and international presentations and is considered an expert in cognitive rehabilitation in multiple sclerosis.

Dawn Langdon, PhD is Professor of Neuropsychology at Royal Holloway University of London. She is neuropsychology lead on a number of multinational trials for the pharmaceutical industry. She has worked extensively on psychological aspects of MS, including measurement of cognition and its relation to pathology and other disease variables. She is Co-Chair of the BICAMS (Brief International Cognitive Assessment for MS) which has recommended a brief cognition tool for MS. Over 30 peer review journal articles recommend BICAMS for routine assessment. BICAMS has been used in a number of international pharma trials and also in other investigations of MS cognition relating to imaging, employment and everyday life tasks.

Kathy Zackowski, PhD is the Associate Vice President for Research at the National MS Society. She manages the Society’s research portfolio on clinical and rehabilitation care, leads the development of the Society’s Wellness Initiative, and facilitates the Society’s Community Review of MS Research committee. In addition, Dr. Zackowski serves on the scientific leadership team of the International Progressive MS Alliance. Prior to being at the Society she was at Johns Hopkins School of Medicine as a researcher focused on neuroscience and motor control and as a clinician providing occupational therapy to individuals with multiple sclerosis.

Host

Angela White has been a leader in the MS movement since her diagnosis of multiple sclerosis in 2002. As volunteer for the National MS Society, U.S., she has advocated for needed change in public policy, served as a committee member of the Black MS Experience Summit and reviewed MS research applications. She also is engaged in the MS International Federation’s Patient Reported Outcomes Initiative. Angela is certified as a group fitness instructor and as a specialist in fitness nutrition. She is currently laying the groundwork to offer classes for people living with mobility and neurological challenges, both locally and virtually.

About the International Progressive MS Alliance

The International Progressive MS Alliance is a first-of-its-kind global research network aimed at accelerating the development of new, effective treatments for progressive MS. We are rallying the world through an unprecedented collaboration of MS organisations, researchers, healthcare professionals, pharmaceutical companies, foundations, donors and people affected by MS. Our promise is more than hope; it is progress.

MSIF is proud to be a leading member of the International Progressive MS Alliance.